YHO-13177 is primarily utilized in the field of medicinal chemistry for its potential as a therapeutic agent. It has shown promising activity in targeting specific biological pathways, making it a candidate for drug development in treating certain diseases. Researchers are exploring its efficacy in inhibiting enzymes or receptors involved in pathological conditions, such as cancer or inflammatory disorders. Its application extends to preclinical studies, where it is being evaluated for its pharmacokinetic properties, safety profile, and therapeutic effectiveness. Additionally, YHO-13177 is being investigated for its role in combination therapies, potentially enhancing the efficacy of existing treatments. Its development underscores its potential to contribute to the advancement of targeted and personalized medicine.